Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edelgard Lindhoff-Last

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
VASA. Zeitschrift Fur Gefasskrankheiten|March 10, 2012
Late peripheral stent thrombosis due to stent fracture, vigorous exercise and hyporesponsiveness to clopidogrelBirgit Linnemann, Axel Thalhammer, Zsuzsanna Wolf, et al.
Thrombosis and Haemostasis|October 7, 2009
Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)Beate Luxembourg, Joern Schmitt, Marek Humpich, et al.
Plos One|August 23, 2012
No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic strokeFerdinand Bohmann, Ana Mirceska, Josef Pfeilschifter, et al.
Hamostaseologie|February 12, 2026
Thrombophilia Testing in Women and Adolescent Girls-Position Paper from the Standing Committee on Women's Health Issues of the Society for Thrombosis and Haemostasis Research (GTH)Birgit Linnemann, Rupert Bauersachs, Frauke Bergmann, et al.
Thrombosis and Haemostasis|January 12, 2012
Performance of five D-dimer assays for the exclusion of symptomatic distal leg vein thrombosisBeate Luxembourg, Jan Schwonberg, Carola Hecking, et al.
Thrombosis and Haemostasis|January 18, 2006
Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharidesRalf J Ludwig, Marc Schindewolf, Susanne Alban, et al.
Therapeutic Drug Monitoring|September 17, 2010
Assays for measuring rivaroxaban: their suitability and limitationsEdelgard Lindhoff-Last, Meyer Michel Samama, Thomas L Ortel, et al.
JACC. Clinical Electrophysiology|March 23, 2019
Thrombus Formation in Isolated Left Atrial Appendage After Multiple Atrial Fibrillation Ablations Despite Oral Anticoagulation Followed by Percutaneous Appendage ClosureShaojie Chen, Boris Schmidt, Stefano Bordignon, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Prevalence of established risk factors for venous thromboembolism according to ageBirgit Linnemann, Lea Weingarz, Marc Schindewolf, et al.
Minerva Anestesiologica|February 16, 2021
Direct oral anticoagulants in point-of-care monitoring: an ex-vivo studyMatthias Klages, Florian J Raimann, Anna-Lena Philipp, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
VASA. Zeitschrift Fur Gefasskrankheiten|March 10, 2012
Late peripheral stent thrombosis due to stent fracture, vigorous exercise and hyporesponsiveness to clopidogrelBirgit Linnemann, Axel Thalhammer, Zsuzsanna Wolf, et al.
Thrombosis and Haemostasis|October 7, 2009
Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)Beate Luxembourg, Joern Schmitt, Marek Humpich, et al.
Plos One|August 23, 2012
No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic strokeFerdinand Bohmann, Ana Mirceska, Josef Pfeilschifter, et al.
Hamostaseologie|February 12, 2026
Thrombophilia Testing in Women and Adolescent Girls-Position Paper from the Standing Committee on Women's Health Issues of the Society for Thrombosis and Haemostasis Research (GTH)Birgit Linnemann, Rupert Bauersachs, Frauke Bergmann, et al.
Thrombosis and Haemostasis|January 12, 2012
Performance of five D-dimer assays for the exclusion of symptomatic distal leg vein thrombosisBeate Luxembourg, Jan Schwonberg, Carola Hecking, et al.
Thrombosis and Haemostasis|January 18, 2006
Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharidesRalf J Ludwig, Marc Schindewolf, Susanne Alban, et al.
Therapeutic Drug Monitoring|September 17, 2010
Assays for measuring rivaroxaban: their suitability and limitationsEdelgard Lindhoff-Last, Meyer Michel Samama, Thomas L Ortel, et al.
JACC. Clinical Electrophysiology|March 23, 2019
Thrombus Formation in Isolated Left Atrial Appendage After Multiple Atrial Fibrillation Ablations Despite Oral Anticoagulation Followed by Percutaneous Appendage ClosureShaojie Chen, Boris Schmidt, Stefano Bordignon, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
Prevalence of established risk factors for venous thromboembolism according to ageBirgit Linnemann, Lea Weingarz, Marc Schindewolf, et al.
Minerva Anestesiologica|February 16, 2021
Direct oral anticoagulants in point-of-care monitoring: an ex-vivo studyMatthias Klages, Florian J Raimann, Anna-Lena Philipp, et al.
Pageof 12